We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+15.71%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.92B
AUM Growth
+$466M
Cap. Flow
-$28.9M
Cap. Flow %
-0.49%
Top 10 Hldgs %
26.27%
Holding
163
New
16
Increased
58
Reduced
30
Closed
24

Top Buys

Rank Stock Value
1
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$87.6M
2
GH icon
Guardant Health
GH
+$61.3M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$37.2M
4
TOST icon
Toast
TOST
+$32M
5
LAD icon
Lithia Motors
LAD
+$28.4M

Top Sells

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$71.9M
2
DOCS icon
Doximity
DOCS
+$45M
3
ENPH icon
Enphase Energy
ENPH
+$36M
4
ROP icon
Roper Technologies
ROP
+$31.6M
5
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$31.6M

Sector Composition

Rank Sector Weight
1 Healthcare 43.76%
2 Technology 22.95%
3 Industrials 13.17%
4 Consumer Discretionary 7.97%
5 Utilities 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDNY
26
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$74M 1.25%
1,927,000
+487,436
+34% +$12.5M
KRTX
27
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$73.7M 1.25%
339,968
+70
+0% +$15K
DV icon
28
DoubleVerify
DV
$1.69B
$73.4M 1.24%
1,884,837
+16,596
+0.9% +$536K
CRWD icon
29
CrowdStrike
CRWD
$189B
$73M 1.23%
1,989,336
+4,988
+0.3% +$174K
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$70.9M 1.2%
689,708
-110,743
-14% -$11.7M
DLO icon
31
dLocal
DLO
$4.41B
$69.6M 1.18%
5,699,607
+1,242,363
+28% +$16.4M
SWAV
32
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$69.2M 1.17%
242,457
+582
+0.2% +$162K
XMTR icon
33
Xometry
XMTR
$4.69B
$67.6M 1.14%
3,190,690
+287,761
+10% +$5.03M
SHLS icon
34
Shoals Technologies Group
SHLS
$1.49B
$62.8M 1.06%
2,456,462
+281,373
+13% +$6.51M
TREX icon
35
Trex
TREX
$4.56B
$57.9M 0.98%
882,499
+265
+0% +$14.8K
FIVN icon
36
FIVE9
FIVN
$2.12B
$57.2M 0.97%
693,408
-372,042
-35% -$25M
COLL icon
37
Collegium Pharmaceutical
COLL
$1.17B
$56.5M 0.96%
2,631,257
+1,120
+0% +$25.4K
ENTG icon
38
Entegris
ENTG
$17.8B
$56.3M 0.95%
507,676
-95,007
-16% -$8.66M
MPWR icon
39
Monolithic Power Systems
MPWR
$64.7B
$52.6M 0.89%
97,351
+20
+0% +$9.5K
ASND icon
40
Ascendis Pharma A/S
ASND
$16.5B
$51.4M 0.87%
575,432
-207,408
-26% -$18.1M
ASML icon
41
ASML
ASML
$634B
$50.2M 0.85%
69,288
+66
+0.1% +$44.9K
DDOG icon
42
Datadog
DDOG
$95.6B
$48.8M 0.82%
495,873
+641
+0.1% +$53.6K
CLDX icon
43
Celldex Therapeutics
CLDX
$3.02B
$46.7M 0.79%
1,377,740
– –
SPT icon
44
Sprout Social
SPT
$509M
$46.3M 0.78%
1,002,754
+127,488
+15% +$6.06M
LNG icon
45
Cheniere Energy
LNG
$54.1B
$45.9M 0.78%
301,193
+117
+0% +$17.3K
COUR icon
46
Coursera
COUR
$1.51B
$44.3M 0.75%
3,402,095
-927
-0% -$11.1K
NVT icon
47
nVent Electric
NVT
$23.4B
$41.5M 0.7%
802,503
– –
LSCC icon
48
Lattice Semiconductor
LSCC
$17.7B
$41.1M 0.69%
427,941
-84,908
-17% -$7.31M
COGT icon
49
Cogent Biosciences
COGT
$7.07B
$40.7M 0.69%
3,440,796
+851,018
+33% +$9.76M
BEP icon
50
Brookfield Renewable
BEP
$9.9B
$36.4M 0.62%
1,236,000
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Eventide Asset Management held 163 positions worth $5.92B, up 8.6% from $5.45B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management's Q2 2023 filing shows 16 new, 58 increased, 30 reduced and 24 closed positions. Its largest new stake was Toast: 1,603,866 shares worth $36.2M. The largest sale was Prometheus Biosciences, Inc. Common Stock, an estimated $71.9M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2023 buy was Toast: 1,603,866 shares worth $36.2M.
  • Eventide Asset Management added most to Zentalis Pharmaceuticals in Q2 2023, an estimated $87.6M increase.
  • Eventide Asset Management's biggest Q2 2023 reduction was Doximity, cutting an estimated $45M.
  • Eventide Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $71.9M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $5.92B portfolio in Q2 2023.
  • Eventide Asset Management opened 16 new positions and closed 24 in Q2 2023.
  • Eventide Asset Management's portfolio value rose 8.6% quarter-over-quarter to $5.92B.

Based on Eventide Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.